DR. GERALD NOVAK, M.D.
Medical Practice at Concord Ln, Montgomery, NJ
License number
New Jersey 144522
Category
Medical Practice
Type
Neurodevelopmental Disabilities
Address
Address
17 Concord Ln, Montgomery, NJ 08558
Phone
(908) 229-9328
(609) 730-2069 (Fax)
(609) 730-2069 (Fax)
Personal information
See more information about GERALD NOVAK at radaris.comName
Address
Phone
52 Shady Ave, Haskell, NJ 07420
16 Sunset Dr, N Caldwell, NJ 07006
16 Dawnwinds Ct, Lakewood, NJ 08701
150 Knickerbocker Ave, Hillsdale, NJ 07642
1201 Mount Kemble Ave, Morristown, NJ 07960
Professional information
Methods Of Treating Epileptogenesis And Epilepsy
US Patent:
2011015, Jun 23, 2011
Filed:
Nov 15, 2007
Appl. No.:
11/940710
Inventors:
Yong Moon CHOI - Pine Brook NJ, US
Robert Gordon - Robbinsville NJ, US
Gerald P. Novak - Skillman NJ, US
Carlos R. Plata-Salaman - Zionsville IN, US
Roy E. Twyman - Doylestown PA, US
H. Steve White - Salt Lake City UT, US
Boyu Zhao - Lansdale PA, US
Robert Gordon - Robbinsville NJ, US
Gerald P. Novak - Skillman NJ, US
Carlos R. Plata-Salaman - Zionsville IN, US
Roy E. Twyman - Doylestown PA, US
H. Steve White - Salt Lake City UT, US
Boyu Zhao - Lansdale PA, US
International Classification:
A61K 31/27, A61P 25/08
US Classification:
514479, 514478, 514483
Abstract:
This invention is directed to methods for preventing, treating, reversing, inhibiting or arresting epilepsy and epileptogenesis in a subject comprising administering to the subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II), or a pharmaceutically acceptable salt or ester thereof:wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R, R, R, R, Rand Rare independently selected from the group consisting of hydrogen and C-Calkyl; wherein C-Calkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C-Calkyl, C-Calkoxy, amino, nitro and cyano).
Methods For Qt Interval Control
US Patent:
2007001, Jan 11, 2007
Filed:
Jan 11, 2006
Appl. No.:
11/329757
Inventors:
Gerald Novak - Skillman NJ, US
Luc Truyen - Pennington NJ, US
Eric Yuen - Blue Bell PA, US
Luc Truyen - Pennington NJ, US
Eric Yuen - Blue Bell PA, US
International Classification:
A61K 31/325
US Classification:
514483000, 514489000
Abstract:
This invention is directed to methods for controlling the duration of the depolarization and repolarization of the cardiac ventricle and therefore the QT interval, in therapeutically useful ways in a subject, comprising administering to the subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II), or a pharmaceutically acceptable salt or ester thereof:
wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R, R, R, R, Rand Rare independently selected from the group consisting of hydrogen and C-Calkyl; wherein C-Calkyl is optionally substituted with phenyl, wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C-Calkyl, C-Calkoxy, amino, nitro and cyano.
Methods Of Treating Epileptogenesis And Epilepsy
US Patent:
2006019, Aug 31, 2006
Filed:
Sep 15, 2005
Appl. No.:
11/227247
Inventors:
Yong Choi - Pine Brook NJ, US
Robert Gordon - Robbinsville NJ, US
Gerald Novak - Skillman NJ, US
Carlos Plata-Salaman - Zionsville IN, US
Roy Twyman - Doylestown PA, US
H. White - Salt Lake City UT, US
Boyu Zhao - Lansdale PA, US
Robert Gordon - Robbinsville NJ, US
Gerald Novak - Skillman NJ, US
Carlos Plata-Salaman - Zionsville IN, US
Roy Twyman - Doylestown PA, US
H. White - Salt Lake City UT, US
Boyu Zhao - Lansdale PA, US
International Classification:
A61K 31/325
US Classification:
514483000, 514489000
Abstract:
This invention is directed to methods for preventing, treating, reversing, inhibiting or arresting epilepsy and epileptogenesis in a subject comprising administering to the subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II), or a pharmaceutically acceptable salt or ester thereof:
wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R, R, R, R, Rand Rare independently selected from the group consisting of hydrogen and C-Calkyl; wherein C-Calkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C-Calkyl, C-Calkoxy, amino, nitro and cyano).